Genmab To Issue Restricted Stock Units To Board Members As Renumeration

October 07, 2026 — 05:08 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Genmab A/S (GMAB), a biotechnology company, on Wednesday reported the results of an Extraordinary General Meeting to determine a share-based renumeration for the company's Board of Directors.

The meeting resulted in the approval of the proposal from the Board to provide its members with restricted stock units in accordance with the company's Renumeration Policy.

A total of 5,300 restricted stock units were granted to the Board cost-free, with each unit giving the owner conditional rights to receive one share in Genmab A/S worth DKK 1. The fair value of each share is equal to the closing price on the granting date, that is, DKK 2,487.

The stock units will vest on the first banking day of the month following a period of three years from the date of granting.

GMAB closed Wednesday at $36.65, down 3.04%.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Genmab To Issue Restricted Stock Units To Board Members As Renumeration

Tags

Latest Articles